These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12202898)

  • 1. [Weekly Taxol (Paclitaxel) administration in the second-line treatment of breast cancer].
    Dank M
    Magy Onkol; 2002; 46(2):189-91. PubMed ID: 12202898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of weekly paclitaxel administration for metastatic breast cancer based on time to progression (TTP) and survival].
    Emoto T; Yoshikawa K; Yoshioka Y; Nezu R; Fujikawa M; Fujii M; Maeda S; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):817-22. PubMed ID: 12852349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
    Kimura M; Koida T; Yanagita Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
    Campone M; Fumoleau P
    Bull Cancer; 2002 Mar; 89(3):275-82. PubMed ID: 11940467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly paclitaxel in women with heavily pretreated metastatic breast cancer: a retrospective analysis of cases treated at the Chang Gung Memorial Hospital.
    Lu CH; Lin YC; Chang HK
    Chang Gung Med J; 2007; 30(1):33-40. PubMed ID: 17477027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
    Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
    Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paclitaxel].
    Omuro Y; Sasaki T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1357-62. PubMed ID: 11681242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
    Kodera Y; Ito S; Mochizuki Y; Fujitake S; Koshikawa K; Kanyama Y; Matsui T; Kojima H; Takase T; Ohashi N; Fujiwara M; Sakamoto J; Akimasa N;
    Anticancer Res; 2007; 27(4C):2667-71. PubMed ID: 17695430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
    Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
    Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
    J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
    Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.
    Kimura M; Sano M; Fujimori M; Nakagomi H; Negishi T; Yanagita Y; Sato N
    Anticancer Res; 2008; 28(2B):1239-44. PubMed ID: 18505061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
    Nishimura H; Hamanaka K; Sakai H; Ohno Y; Miyagawa Y; Seki H; Munakata Y
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):627-30. PubMed ID: 15114714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy].
    Cho H; Kanari M; Sano H; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Imada T
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):129-32. PubMed ID: 12557718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
    Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J
    Breast Cancer Res Treat; 2008 Mar; 108(2):241-50. PubMed ID: 17476588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of weekly docetaxel and concurrent radiation for advanced breast cancer--case report].
    Kashiyama S; Ohnishi H; Kuriyama K; Komiyama T; Marino K; Araki T
    Gan To Kagaku Ryoho; 2005 May; 32(5):679-82. PubMed ID: 15918572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
    Winer EP; Berry DA; Woolf S; Duggan D; Kornblith A; Harris LN; Michaelson RA; Kirshner JA; Fleming GF; Perry MC; Graham ML; Sharp SA; Keresztes R; Henderson IC; Hudis C; Muss H; Norton L
    J Clin Oncol; 2004 Jun; 22(11):2061-8. PubMed ID: 15169793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.